PRKCI expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.52279991236537E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.05489991478692E-10 |
Normal-vs-Stage2 |
2.40730000000688E-06 |
Normal-vs-Stage3 |
3.04059999400863E-09 |
Normal-vs-Stage4 |
1.74100001082422E-09 |
Stage1-vs-Stage2 |
5.722600E-01 |
Stage1-vs-Stage3 |
7.533400E-01 |
Stage1-vs-Stage4 |
8.475800E-01 |
Stage2-vs-Stage3 |
5.208000E-01 |
Stage2-vs-Stage4 |
5.310800E-01 |
Stage3-vs-Stage4 |
8.854600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.52660028851903E-10 |
Normal-vs-AfricanAmerican |
1.27590005227773E-09 |
Normal-vs-Asian |
5.225600E-02 |
Caucasian-vs-AfricanAmerican |
5.376600E-01 |
Caucasian-vs-Asian |
5.977400E-01 |
AfricanAmerican-vs-Asian |
3.703000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.42510003797724E-10 |
Normal-vs-Female |
1.43889999915103E-08 |
Male-vs-Female |
9.605700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.33159999996069E-06 |
Normal-vs-Age(41-60Yrs) |
3.18219994799307E-09 |
Normal-vs-Age(61-80Yrs) |
3.87490040054672E-10 |
Normal-vs-Age(81-100Yrs) |
2.43230002805461E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.870800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.649400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.310600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.294600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.792100E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.359600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.07739999980028E-07 |
Normal-vs-Grade 2 |
8.94919693905649E-11 |
Normal-vs-Grade 3 |
2.02920014125141E-10 |
Normal-vs-Grade 4 |
7.42500505523935E-11 |
Grade 1-vs-Grade 2 |
7.958600E-01 |
Grade 1-vs-Grade 3 |
1.442600E-01 |
Grade 1-vs-Grade 4 |
4.208100E-02 |
Grade 2-vs-Grade 3 |
1.490840E-01 |
Grade 2-vs-Grade 4 |
4.010400E-02 |
Grade 3-vs-Grade 4 |
3.014000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.06949999967298E-08 |
Normal-vs-ccB subtype |
6.07860428658569E-11 |
ccA subtype-vs-ccB subtype |
3.887600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.99589999872308E-09 |
Normal-vs-N1 |
6.215600E-04 |
N0-vs-N1 |
7.526000E-01 |
|
|